Search Results - "Fournier, Pierrick G.J."

Refine Results
  1. 1

    The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone by Fournier, Pierrick G.J., Juárez, Patricia, Jiang, Guanglong, Clines, Gregory A., Niewolna, Maria, Kim, Hun Soo, Walton, Holly W., Peng, Xiang Hong, Liu, Yunlong, Mohammad, Khalid S., Wells, Clark D., Chirgwin, John M., Guise, Theresa A.

    Published in Cancer cell (08-06-2015)
    “…Transforming growth factor-β (TGF-β) regulates the expression of genes supporting breast cancer cells in bone, but little is known about prostate cancer bone…”
    Get full text
    Journal Article
  2. 2

    Molecular Biology of Bone Metastasis by Kingsley, Lauren A, Fournier, Pierrick G J, Chirgwin, John M, Guise, Theresa A

    Published in Molecular cancer therapeutics (01-10-2007)
    “…Metastasis is a final stage of tumor progression. Breast and prostate cancer cells preferentially metastasize to bone, wherein they cause incurable osteolytic…”
    Get full text
    Journal Article
  3. 3

    Bisphosphonates and cancer-induced bone disease : Beyond their antiresorptive activity by CLEZARDIN, Philippe, EBETINO, Frank H, FOURNIER, Pierrick G. J

    Published in Cancer research (Chicago, Ill.) (15-06-2005)
    “…Bisphosphonates are primarily known for their ability to inhibit osteoclast-mediated bone resorption. They are an indispensable part of therapy for patients…”
    Get full text
    Journal Article
  4. 4

    Lowering bone mineral affinity of bisphosphonates as a therapeutic strategy to optimize skeletal tumor growth inhibition in vivo by Fournier, Pierrick G J, Daubiné, Florence, Lundy, Mark W, Rogers, Michael J, Ebetino, Frank H, Clézardin, Philippe

    Published in Cancer research (Chicago, Ill.) (01-11-2008)
    “…Bisphosphonates bind avidly to bone mineral and are potent inhibitors of osteoclast-mediated bone destruction. They also exhibit antitumor activity in vitro…”
    Get full text
    Journal Article
  5. 5

    TGF-β-RI Kinase Inhibitor SD-208 Reduces the Development and Progression of Melanoma Bone Metastases by MOHAMMAD, Khalid S, JAVELAUD, Delphine, FOURNIER, Pierrick G. J, NIEWOLNA, Maria, RYAN MCKENNA, C, PENG, Xiang H, DUONG, Vu, DUNN, Lauren K, MAUVIEL, Alain, GUISE, Theresa A

    Published in Cancer research (Chicago, Ill.) (01-01-2011)
    “…Melanoma often metastasizes to bone where it is exposed to high concentrations of TGF-β. Constitutive Smad signaling occurs in human melanoma. Because TGF-β…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Abstract 5812: Development of αVβ5 + exosomes for liver-targeted therapy by Montaño, Paloma Acosta, Félix, Eréndira Olvera, Flores, Verónica Castro, Juárez, Patricia, Fournier, Pierrick G.J.

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Liver metastases are common in pancreatic and colorectal cancer. Their development is promoted by tumor-secreted exosomes that, thanks to the presence of the…”
    Get full text
    Journal Article
  8. 8

    Abstract 5281: 5-Fluorouracil decreases MDSC and the development of osteolytic bone metastases from breast cancer in mice by Fournier, Pierrick G.J., Luna, Paloma Almeida, Arellano, Danna, Jiménez, Samanta, Olvera, Felipe, Juárez, Patricia

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Bone metastases are a highly debilitating complication in more than 70% of patients with advanced breast and prostate cancer. Currently approved treatments…”
    Get full text
    Journal Article
  9. 9

    Contribution of Macrophages and T Cells in Skeletal Metastasis by Mendoza-Reinoso, Veronica, McCauley, Laurie K, Fournier, Pierrick G J

    Published in Cancers (20-04-2020)
    “…Bone is a common site for metastases with a local microenvironment that is highly conducive for tumor establishment and growth. The bone marrow is replete with…”
    Get full text
    Journal Article
  10. 10

    Abstract 4147: Chitosan luminescent rare-earth doped nanoparticles as cancer cell tracking for imaging tumors and their immune response by Osorio-Arciniega, Rodrigo, Lucero-Meza, Eduardo, Can-Uc, Bonifacio, Rocha-Mendoza, Israel, Fournier, Pierrick G.J., Hirata, Gustavo A, Juarez, Patricia

    Published in Cancer research (Chicago, Ill.) (22-03-2024)
    “…Background: Cancer is a group of diseases characterized by the unregulated growth of cells, which can be hard to diagnose due to the high false negatives or…”
    Get full text
    Journal Article
  11. 11

    Hypoxia and TGF-beta drive breast cancer bone metastases through parallel signaling pathways in tumor cells and the bone microenvironment by Dunn, Lauren K, Mohammad, Khalid S, Fournier, Pierrick G J, McKenna, C Ryan, Davis, Holly W, Niewolna, Maria, Peng, Xiang Hong, Chirgwin, John M, Guise, Theresa A

    Published in PloS one (03-09-2009)
    “…Most patients with advanced breast cancer develop bone metastases, which cause pain, hypercalcemia, fractures, nerve compression and paralysis. Chemotherapy…”
    Get full text
    Journal Article
  12. 12

    Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis by Juárez, Patricia, Fournier, Pierrick G J, Mohammad, Khalid S, McKenna, Ryan C, Davis, Holly W, Peng, Xiang H, Niewolna, Maria, Mauviel, Alain, Chirgwin, John M, Guise, Theresa A

    Published in Oncotarget (17-10-2017)
    “…More efficient therapies that target multiple molecular mechanisms are needed for the treatment of incurable bone metastases. Halofuginone is a plant…”
    Get full text
    Journal Article
  13. 13

    Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy by Sengar, Prakhar, Juárez, Patricia, Verdugo-Meza, Andrea, Arellano, Danna L, Jain, Akhil, Chauhan, Kanchan, Hirata, Gustavo A, Fournier, Pierrick G J

    Published in Journal of nanobiotechnology (27-02-2018)
    “…Photodynamic therapy is a promising cancer therapy modality but its application for deep-seated tumor is mainly hindered by the shallow penetration of visible…”
    Get full text
    Journal Article
  14. 14

    Functionalized rare earth-doped nanoparticles for breast cancer nanodiagnostic using fluorescence and CT imaging by Jain, Akhil, Fournier, Pierrick G J, Mendoza-Lavaniegos, Vladimir, Sengar, Prakhar, Guerra-Olvera, Fernando M, Iñiguez, Enrique, Kretzschmar, Thomas G, Hirata, Gustavo A, Juárez, Patricia

    Published in Journal of nanobiotechnology (22-03-2018)
    “…Breast cancer is the second leading cause of cancer death among women and represents 14% of death in women around the world. The standard diagnosis method for…”
    Get full text
    Journal Article
  15. 15

    Halofuginone Inhibits the Establishment and Progression of Melanoma Bone Metastases by JUAREZ, Patricia, MOHAMMAD, Khalid S, MAUVIEL, Alain, GUISE, Theresa A, JUAN JUAN YIN, FOURNIER, Pierrick G. J, MCKENNA, Ryan C, DAVIS, Holly W, PENG, Xiang H, NIEWOLNA, Maria, JAVELAUD, Delphine, CHIRGWIN, John M

    Published in Cancer research (Chicago, Ill.) (01-12-2012)
    “…TGF-β derived from bone fuels melanoma bone metastases by inducing tumor secretion of prometastatic factors that act on bone cells to change the skeletal…”
    Get full text
    Journal Article
  16. 16

    The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm by Trivedi, Trupti, Zheng, Yu, Fournier, Pierrick G J, Murthy, Sreemala, John, Sutha, Schillo, Suzanne, Dunstan, Colin R, Mohammad, Khalid S, Zhou, Hong, Seibel, Markus J, Guise, Theresa A

    Published in Oncotarget (18-04-2017)
    “…Vitamin D has pleiotropic effects on multiple tissues, including malignant tumors. Vitamin D inhibits breast cancer growth through activation of the vitamin D…”
    Get full text
    Journal Article
  17. 17

    TIE2 Induces Breast Cancer Cell Dormancy and Inhibits the Development of Osteolytic Bone Metastases by Drescher, Florian, Juárez, Patricia, Arellano, Danna L, Serafín-Higuera, Nicolás, Olvera-Rodriguez, Felipe, Jiménez, Samanta, Licea-Navarro, Alexei F, Fournier, Pierrick Gj

    Published in Cancers (03-04-2020)
    “…Breast cancer (BCa) cells disseminating to the bone can remain dormant and resistant to treatments for many years until relapsing as bone metastases. The…”
    Get full text
    Journal Article
  18. 18

    Monocytic Myeloid-Derived Suppressor Cells from Tumor Tissue Are a Differentiated Cell with Limited Fate Plasticity by Calvert, Ryan D, Fleet, James C, Fournier, Pierrick G J, Juarez, Patricia, Burcham, Grant N, Haverkamp, Jessica M, Guise, Theresa A, Ratliff, Timothy L, Elzey, Bennett D

    Published in ImmunoHorizons (01-12-2022)
    “…Owing to ease of access and high yield, most murine myeloid-derived suppressor cell (MDSC) knowledge comes from the study of spleen-derived MDSCs rather than…”
    Get full text
    Journal Article
  19. 19
  20. 20